Oncotarget

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Oncotarget  
LanguageEnglish
Edited byMikhail Blagosklonny, Andrei V. Gudkov
Publication details
Publication history
2010-present
Publisher
FrequencyWeekly
Yes
LicenseCreative Commons Attribution 3.0 License
5.168
Standard abbreviations
Oncotarget
Indexing
ISSN1949-2553
OCLC no.408119940
Links

Oncotarget is a twice weekly peer-reviewed open access bio-medical journal covering research on all aspects of oncology and publishing sub-sections on topics beyond oncology. The journal was established in 2010 and is published by Impact Journals. The editors-in-chief are Mikhail Blagosklonny and Andrei V. Gudkov.

In 2017, the journal was dropped from MEDLINE.[1][2] In 2018 Clarivate Analytics delisted the journal from the Journal Citation Reports and all of its other products because "the journal no longer meets the standards necessary for continued coverage",[3] despite having listed the journal as a "Rising Star from Essential Science Indicators"[4] only a few months prior.[5]

Abstracting and indexing[edit]

The journal is abstracted and indexed in PubMed[6], Meta,[7][8][9] and Scopus.[10] It was dropped from Index Medicus/MEDLINE[1][2][6] in 2017 and in 2018 from BIOSIS Previews and the Science Citation Index Expanded.[3]

Reception[edit]

The peer review process employed by the journal has been criticized by Jeffrey Beall,[11] a university librarian and expert on predatory open access publishing, who also included the journal on his list of "potential, possible, or probable predatory scholarly open-access journals" in July 2015.[11][12] Allegedly, journal editor Mikhail Blagosklonny responded by threatening to retract the papers of Beall's colleagues at the University of Colorado.[1][2]

References[edit]

  1. ^ a b c "Widely used U.S. government database delists cancer journal". Retraction Watch. October 25, 2017. Retrieved October 25, 2017.
  2. ^ a b c Zimmer, Katarina (October 26, 2017). "Oncotarget Journal Cut from Medline". The Scientist.
  3. ^ a b "Indexing company praises cancer journal, then kicks it out". Retraction Watch. 2018-01-19. Retrieved 2018-01-20.
  4. ^ "Rising Stars from Essential Science Indicators". Clarivate Analytics. 2017-10-18. Retrieved 2018-01-21.
  5. ^ "Indexing company praises cancer journal, then kicks it out". Retraction Watch. 2018-01-19. Retrieved 2018-01-21.
  6. ^ a b "Oncotarget". NLM Catalog. National Center for Biotechnology Information. Retrieved 2016-04-19.
  7. ^ "Oncotarget | In The News - Press Releases". Retrieved 2018-03-15.
  8. ^ "When a journal is delisted, authors pay a price". Retraction Watch. 2018-03-06. Retrieved 2018-03-15.
  9. ^ Oncotarget. "Oncotarget to be Indexed in Highly Esteemed Meta Database". www.prnewswire.com. Retrieved 2018-03-15.
  10. ^ "Source details: Oncotarget". Scopus preview. Elsevier. Retrieved 2018-01-27.
  11. ^ a b Beall, Jeffrey (19 April 2016). "Oncotarget's Peer Review is Highly Questionable". Scholarly Open Access. WordPress.com. Archived from the original on 20 April 2016. Retrieved 19 April 2016.
  12. ^ Beall, Jeffrey (16 April 2016). "LIST OF STANDALONE JOURNALS: Potential, possible, or probable predatory scholarly open-access journals". Scholarly Open Access. WordPress.com. Archived from the original on 2 December 2016. Retrieved 19 April 2016.

External links[edit]